Skip to main content

Molecular Genetics of Retrovirus and Mobile DNA

RYC2021-031920-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

LINE-1 retrotransposons contribute to mouse PV interneuron development

  • Bodea, Gabriela O.
  • Sánchez-Luque, Francisco J.
  • Rasmussen, Jay
  • Jansz, Natasha
  • Gerdes, Patricia
  • Ajjikuttira, Prabha
  • Billon, Victor
  • Kempen, Marie-Jeanne H.C.
  • Ewing, Adam D.
  • Richardson, Sandra R.
  • Faulkner, Geoffrey J.
Bodea, G.O., Faulkner, Geoffrey J. et al., Retrotransposons are mobile DNA sequences duplicated via transcription and reverse transcription of an RNA intermediate. Cis-regulatory elements encoded by retrotransposons can also promote the transcription of adjacent genes. Somatic LINE-1 (L1) retrotransposon insertions have been detected in mammalian neurons. It is, however, unclear whether L1 sequences are mobile in only some neuronal lineages or therein promote neurodevelopmental gene expression. Here we report programmed L1 activation by SOX6, a transcription factor critical for parvalbumin (PV) interneuron development. Mouse PV interneurons permit L1 mobilization in vitro and in vivo, harbor unmethylated L1 promoters and express full-length L1 mRNAs and proteins. Using nanopore long-read sequencing, we identify unmethylated L1s proximal to PV interneuron genes, including a novel L1 promoter-driven Caps2 transcript isoform that enhances neuron morphological complexity in vitro. These data highlight the contribution made by L1 cis-regulatory elements to PV interneuron development and transcriptome diversity, uncovered due to L1 mobility in this milieu., This work was supported by NHMRC-ARC Dementia Research Development Fellowship GNT1108258 and DFG fellowship BO4460/1-1 (G.O.B.), Australian Government Research Training Program (RTP) Scholarships (J.M.B., M.E.F. and J.d.l.R.B.), NHMRC Investigator Grants GNT1176574 (N.J.), GNT1173476 (S.R.R.) and GNT1173711 (G.J.F.), ARC Discovery Project DP200102919 (S.R.R. and G.J.F.), NHMRC Project Grants GNT1106206 (G.J.F., A.J.H. and L.M.P.) and GNT1126393 (G.J.F.), a CSL Centenary Fellowship (G.J.F.), Andalusian Government EMERGIA20_00225 and Spanish National Research Agency RYC2021_031920-I grants (F.J.S.-L.) and the Mater Foundation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Donor insertion into CX3CR1 allows epigenetic modulation of a constitutive promoter on hematopoietic stem cells and its activation upon myeloid differentiation

  • Ramos-Hernández, Iris
  • Fuster-García, Carla
  • Aguilar-González, Araceli
  • Lozano-Vinagre, María L.
  • Guenechea-Amurrio, Guillermo
  • Sánchez-Luque, Francisco J.
  • Gonçalves, Manuel A. F. V.
  • Cathomen, Toni
  • Muñoz, P.
  • Molina-Estévez, Francisco J.
  • Martín, Francisco
To improve ex vivo gene therapy strategies involving hematopoietic stem and progenitor cells (HSPCs), we propose a novel knock-in strategy (named KI-Ep) aiming to achieve transgene regulation of the inserted cassette through the acquisition of naturally occurring epigenetic marks. Based on this hypothesis, we selected CX3CR1 (a myeloid-specific gene presenting a poised histone signature on primitive HSPCs) as safe harbor to generate KI-Ep HSPCs. We demonstrated that, unlike the expression pattern achieved with lentiviral vectors (LVs), the insertion of a constitutive expression cassette into the intron 1 of the CX3CR1 locus (CX3CR1-I) in HSPCs resulted in very low expression levels in the more primitive HSPCs but, crucially, strong expression in HSPC-differentiated populations (especially myeloid cells), both in vitro and in vivo. Furthermore, we showed that the promoter of the expression cassette inserted into CX3CR1-I acquired epigenetic marks associated with poised genes during the HSPC stage. These marks transitioned to activated histone states upon KI-Ep HSPCs differentiation. In summary, here, we introduce the KI-Ep concept which enables the epigenetic modulation of the inserted transgene during the HSPCs stem cell stages and its subsequent activation upon differentiation., This work was supported by the by the Fondo Europeo de Desarrollo Regional (FEDER), NextGenerationEU funds—actions of the Recovery and Resilience Mechanism and the Instituto de Salud Carlos III (ISCIII) through the financing research projects [PI18/00337 and PI21/00298 to F.M., and PI21/00875 to P.M.], networks (RICORS-TerAv [RD21/ 0017/0004 to F.M., P.M. and F-J.M-E.; RD21/0017/0027 to G.G-A.] and personal (FI19/00163 to I.R-H.). By the Consejería de Salud y Familias (Junta de Andalucía), under the 2019 call for “Proyectos Estratégicos I + D + I con incorporación de capital humano” [PEER-0286-2019 to P.M.] and FEDER/European Cohesion Fund (FSE) for Andalucía [PECART-0031-2020 to F.M.]; by the Consejería de Transformación Económica, Industria, Conocimiento y Universidades (Junta de Andalucía) through the EMERGIA EMERGIA2020 programe [EMERGIA20_00049 to P.M.]. By the Pompe Competitive Research Grant Program by SPARK Therapeutics [SPARK-2022-002 to F-J.M-E.]; by the Ministerio de Ciencia, Innovación y Universidades [PID2021-125077OB-C22 to G.G-A]; the Ministerio de Ciencia e innovación (MICIN)—líneas estratégicas [PLEC2021-008094 to F.M.] by Ministerio de Ciencia e innovación (MICIN), Plan de Recuperación, transformación y resilencia, Centro para el Desarrollo Tecnológico Industrial (CDTI) and European Union-Next Generation EU [00123009/SNEO-20191072 and PMPTA22/00060 to F.M.]; by the Spanish National Research Agency [AEI; grants RYC2021-031920-I and CNS2022-136033 to F-J.S-L.]. And by the European Union, Horizon Europe Framework Program through the EIC PathfinderChallenges [X-PAND 101070950 to T.C] and the European Cooperation in Science and Technology (COST) [GeneHumdi-CA21113]. Funding to pay the Open Access publication charges for this article was provided by Instituto de Salud Carlos III (ISCIII) [RD21/ 0017/0004]; Universidad de Granada/CBUA., Peer reviewed